Literature DB >> 8863868

Age-dependent variation in the serum concentration of mannan-binding protein.

J Aittoniemi1, A Miettinen, P Laippala, E Isolauri, J Viikari, T Ruuska, E Soppi.   

Abstract

Mannan-binding protein (MBP) is an acute phase reactant, and its deficiency is associated with the common opsonic defect and suspectibility to infections and atopic constitution. The aim of this study was to investigate the changes occurring in the serum level of MBP in infancy and during later childhood. We studied the serum concentration of MBP in 611 Finnish children of different ages and 110 adults by using an enzyme immunoassay. In an analysis of successive serum samples from infants at the day of birth and at the ages of 1 and 5 months, and at 1 and 2 years, the serum concentration of MBP increased significantly after birth, and was at its highest (the mean and median were 8.13 and 8.49 mgl-1, respectively) at the age of 1 month. After that, it declined to the initial level until the age of 5 months. The MBP concentration continued to decrease during childhood, and after the age of 12 years the MBP values reached the adult level. In Finnish adults the mean and median concentrations of MBP were 4.48 and 4.02 mgl-1, respectively, which seem to be higher than those reported previously in other populations. The high concentration of MBP in infants may best be explained by exposure to novel environmental antigens in early childhood, which suggests a protective role for MBP during the period of immaturity of the immunosystem. In older children the high level of MBP can probably be explained by childhood infections and the ensuing need of MBP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863868     DOI: 10.1111/j.1651-2227.1996.tb14182.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  18 in total

1.  High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates.

Authors:  F N J Frakking; N Brouwer; D Zweers; M P Merkus; T W Kuijpers; M Offringa; K M Dolman
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Mannan binding lectin deficiency and concomitant immunodefects.

Authors:  J Aittoniemi; M Baer; E Soppi; T Vesikari; A Miettinen
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

3.  The significance of IgG subclasses and mannan-binding lectin (MBL) for susceptibility to infection in apparently healthy adults with IgA deficiency.

Authors:  J Aittoniemi; S Koskinen; P Laippala; S Laine; A Miettinen
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).

Authors:  Nenoo Rawal; Rema Rajagopalan; Veena P Salvi
Journal:  Mol Immunol       Date:  2009-08-05       Impact factor: 4.407

5.  Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.

Authors:  D J Sikkema; K E Friedman; B Corsaro; A Kimura; S W Hildreth; D V Madore; S A Quataert
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

6.  Changes in the mannan binding lectin (MBL) concentration in human milk during lactation.

Authors:  Virginie Trégoat; Paul Montagne; Marie-Christine Béné; Gilbert Faure
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

7.  Macrophages are required for neonatal heart regeneration.

Authors:  Arin B Aurora; Enzo R Porrello; Wei Tan; Ahmed I Mahmoud; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

8.  Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.

Authors:  M Cedzynski; J Szemraj; A S Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Mannan-binding lectin in children with Escherichia coli O157:H7 haemmorrhagic colitis and haemolytic uraemic syndrome.

Authors:  F Proulx; E Wagner; B Toledano; H Decaluwe; E G Seidman; G-E Rivard
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum.

Authors:  I Terai; K Kobayashi; M Matsushita; T Fujita
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.